IH
ICC Holdings, Inc. (ICCH)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 EPS was $0.54 vs $0.96 in Q4 2023, as consolidated revenues grew 4.5% YoY to $23.935M on stronger net premiums earned (+10.3% YoY), but higher expenses and lower net unrealized gains weighed on earnings .
- Insurance underwriting metrics were mixed: GAAP combined ratio was 96.3% vs 93.7% a year ago, while the loss ratio was broadly stable YoY (56.2% vs 55.6%); the expense ratio rose to 40.1% (from 38.1%) due to merger/proxy costs .
- Growth remained solid: direct premiums written rose 9.4% YoY to $26.361M; net investment income increased 21.1% YoY to $1.672M on reinvestment at higher yields . Book value per share improved to $22.86 (from $21.35 at 12/31/23) .
- No formal quantitative guidance was provided; management is “very optimistic about 2025” and highlighted ex-merger/proxy FY combined ratio of 99.7% (1.3 pts better vs 2023) .
- Wall Street (S&P Global) consensus estimates were unavailable in our system for ICCH; estimate-based beat/miss analysis could not be performed (see Estimates Context).
What Went Well and What Went Wrong
-
What Went Well
- Premium and earned premium growth: Direct premiums written +9.4% YoY to $26.361M; net premiums earned +10.3% YoY to $22.267M, driven by rate increases and higher policies in force .
- Investment income tailwind: Net investment income +21.1% YoY to $1.672M on redeployments at higher rates; management also noted equity market gains supporting unrealized gains for the full year .
- Operational efficiency and tone: CEO emphasized improving operational efficiencies and a FY 2024 ex-merger/proxy combined ratio of 99.7% (1.3 pts lower than 2023); “very optimistic about 2025” .
-
What Went Wrong
- EPS and YoY profitability: Q4 diluted EPS fell to $0.54 from $0.96 in Q4 2023 despite higher revenues; net earnings declined to $1.608M from $2.861M YoY .
- Expense pressure: Expense ratio rose to 40.1% (from 38.1% YoY) with policy acquisition/operating expenses up 16.1% to $8.935M, citing merger and proxy contest costs .
- Investment mark-to-market in the quarter: Q4 recognized net unrealized losses of $0.084M vs gains of $0.857M in Q4 2023, with underperformance in healthcare, materials, and construction equities .
Financial Results
Revenue, EPS, and profit vs prior periods (oldest → newest)
Insurance margin metrics (oldest → newest)
Operating KPIs (oldest → newest)
Additional balance sheet datapoints
- Book value per share: $22.86 at 12/31/24 (vs $21.35 at 12/31/23) .
- Total equity: $71.746M at 12/31/24 (vs $67.004M at 12/31/23) .
- Total assets: $235.360M at 12/31/24 (vs $211.017M at 12/31/23) .
Segment breakdown: Not disclosed in the Q4 press release; narrative highlights liquor liability and businessowner’s liability as key claim drivers without quantified segment revenues .
Guidance Changes
Earnings Call Themes & Trends
Note: We could not locate a Q4 2024 earnings call transcript in the document catalog; themes are synthesized from the Q2–Q4 press releases.
Management Commentary
- “As our premiums grew in 2024, so to did our operational efficiencies. Our combined ratio excluding merger and resolved proxy contest expenses was 99.7%, or 1.3% lower than our 2023 combined ratio… Our loss and settlement expense ratio remains stable at 63.3% despite a challenging liquor liability market…” — Arron Sutherland, President & CEO .
- “Increased rates and holdings expanded our net investment income. In addition, improvements in the equity markets increased our unrealized gains on investments.” — Arron Sutherland .
- “As we continue to build on our solid foundation, I am very optimistic about 2025.” — Arron Sutherland .
- Prior quarter context: “Losses and settlement expenses are down due to our continued rate strengthening, tighter risk selection, and the introduction of Charlee.ai to improve efficiency and hasten claim resolution.” — Arron Sutherland (Q3 PR) .
Q&A Highlights
- We did not locate a Q4 2024 earnings call transcript; no Q&A highlights are available from primary sources.
Estimates Context
- S&P Global/Capital IQ consensus estimates could not be retrieved for ICCH due to missing company mapping in our SPGI interface; therefore, beat/miss vs Street cannot be assessed from S&P Global in this environment. If you have access to broker estimates, we can reconcile actuals to those figures.
Key Takeaways for Investors
- Underwriting improved sequentially vs Q2’s elevated combined ratio; Q4 combined ratio of 96.3% reflects stable loss ratio and ongoing premium growth, though expense ratio remained elevated given merger/proxy costs .
- Earnings were pressured YoY by higher operating expenses and lower Q4 unrealized investment marks, despite stronger earned premiums and higher net investment income; diluted EPS $0.54 vs $0.96 YoY .
- Growth trajectory intact: DPW +9.4% YoY and NPE +10.3% YoY underscore pricing power and policy expansion in the food & beverage niche .
- Claims mix remains a watch item: liquor liability development continues to be a driver of losses; sustained rate action and risk selection are key mitigants .
- Balance sheet strengthened in 2024: book value/share rose to $22.86; equity and assets expanded on earnings and portfolio growth .
- Investment income provides a durable tailwind into 2025 given higher reinvestment yields, though quarterly equity marks can add noise .
- No formal guidance; CEO’s optimistic tone and ex-one-off combined ratio improvement suggest potential for continued margin normalization post-merger/proxy expense normalization .
Supporting detail (selected):
- Q4 consolidated revenues $23.935M; net earnings $1.608M; diluted EPS $0.54 .
- Q4 combined ratio 96.3% (loss ratio 56.2%, expense ratio 40.1%) .
- DPW $26.361M (+9.4% YoY); NPE $22.267M (+10.3% YoY); NII $1.672M (+21.1% YoY) .
Sources: Q4 2024 8-K/press release and financial statements ; Q3 2024 press release/8-K ; Q2 2024 press release/8-K .